Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 312 results for "cadila health"

Cadila Healthcare recalls blood pressure drug in the US
Financial Express

Cadila recalls drug in US

Mumbai, Oct. 17: Cadila Healthcare has voluntarily recalled 5,400 bottles of anti-hypertension drug Atenolol tablets in the US for failing to meet specifications. A notification by the US Food and Drug Administration (USFDA) said the recall was ... Calcutta Telegraph, 1 month ago
Cadila Healthcare recalls anti-hypertension drug in US Hindu Business Line, 1 month ago
Cadila Healthcare recalls blood pressure drug in the US Business Standard India, 1 month ago
Business Standard India

Pharma index hits new high

Cadila Healthcare, Glenmark Pharm, Dr Reddy's Lab, Sun Pharma and Aurobindo up 1-6%, hits new high today. SI Reporter | Mumbai November 7, 2014 Last Updated at 13:04 IST Shares of pharmaceutical companies are on a roll with the National Stock ...
 Business Standard India3 weeks ago Sun Pharmaceutical Industries, Dr Reddy's face US action on price hikes up to 8,000%  DNA India1 month ago Sun, Reddy's face US action on price spikes [DNA : Daily News & Analysis (India)]  Pharmacy Choice1 month ago India's Pharma industry cures but needs Biotech to sustain  CommodityOnline2 months ago

Cadila recalls chest pain and hypertension tablets in US

Ahmedabad-based Cadila Healthcare's US division has voluntarily initiated recall of 5,400 bottles of atenolol tablets in the United States for failing to meet certain specifications. The drug is used to treat chest pain and hypertension. It is ...
 DNA India1 month ago CADILA HEALTHCARE : recalls chest pain, hypertension tablets in US  4 Traders1 month ago Buy Cadila Health, Canara Bk, Capital First: Dharmesh Kant  Money Control1 month ago Buy Cadila Healthcare; tgt of Rs 1410: Firstcall Research  Moneycontrol.com1 month ago
India TV

Zydus gets tentative nod from USFDA to market diabetic tablets

PTI [ Updated 16 Sep 2014, 16:07:55 ] New Delhi: Drug firm Zydus Cadila has received a tentative nod from the health regulator USFDA to market Glipizide tablets, used for treatment of diabetes, in America. "Zydus Cadila has received tentative ...
 India TV2 months ago Cadila Health up 3%, diabetic drug gets tentative USFDA nod  Money Control2 months ago Zydus gets USFDA tentative nod for diabetic tablets  Press Trust of India2 months ago Zydus receives tentative approval for Glipizide ER tablets  Moneycontrol.com2 months ago

Bull's Eye: Buy Arvind, Cadila Health; short Sesa Sterlite

AK Prabhakar, Independent Advisor advises buying Arvind for a target price of Rs 340 and Sobha Developer for a target price of Rs 488.
 Money Control1 month ago

Pharma firms to be hit as drug regulator caps prices

In a move that might impact major drug makers such as Ranbaxy, Cipla, Cadila Health, and Lupin, the National Pharmaceutical Pricing Authority (NPPA) has capped the prices of 19 medicines and their 43 different drug packs, including anti-infectives, gastro-intestinal drugs and vaccines. Among multinational companies, Pfizer, Sanofi and Reckitt Benckiser are likely to take a hit. NPPA has notified the ceiling price of these products under the Drugs Price Control Order, 2013. In the absence of ...
 Rediff.com2 months ago India Caps Prices of 36 More Drugs to Improve Access  Medscape2 months ago Pharma majors to be hit as drug regulator caps prices  Business Standard India2 months ago UPDATE 2-India caps prices of 36 more drugs to improve access -govt official  Reuters UK2 months ago
Business Standard India

Drug makers sign pact with Gilead for cheaper Hepatitis-C drug

Related to : Cipla Ltd,Ranbaxy Laboratories Ltd,Cadila Healthcare Ltd Cipla Ltd BSE 15 Sep 14 | 12:00 AM 629.70 17.15 (2.8%) NSE 15 Sep 14 | 12:00 AM 630.25 17.5 (2.86%) Seven India-based drug makers Cipla, Ranbaxy, Mylan, ...
 Smart Investor2 months ago A new order  Business Standard India2 months ago Gilead's hepatitis C drug licensing to benefit more patients: Sitharaman  Economic Times2 months ago

CADILA HEALTHCARE : Patent Issued for Process for Preparing Fluticasone Propionate/Furoate

By a News Reporter-Staff News Editor at Pharma Business Week -- A patent by the inventors Solanki, Kirtipalsinh (Ahmedabad, IN); Bavadia, Ruchir Z (Ahmedabad, IN); Patel , Dhaval P (Ahmedabad, IN); Patel , Dhaval J (Ahmedabad, IN); Shah, Tejash C ...
 4 Traders1 month ago

Cadila Pharma organises IAMICON 2014 conclave

Focused on TB and cardiovascular diseases the conclave covered 50 cities; engaged with 20,000 medical professionals Cadila Pharmaceuticals has organised IAMICON 2014 (Indravadan Ambalal Modi Innovation Conclave), scientific conclave for ...
 Financial Express16 hours ago

Top Corporate News of the day-19 November, 2014

Cadila Pharmaceuticals Ltd is now focussing on ayurvedic over-the-counter products segment to fuel growth in the Indian market, which has recently seen several allopathic drugs come under price control. (BS) Ranbaxy Laboratories Ltd has sued the ...
 India Infoline1 week ago Top corporate news of the day - October 20, 2014  India Infoline1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less